Melnikow E, Schoenfeld C, Spehr V, Warrass R, Gunkel N, Duszenko M, Selzer P M, Ullrich H J
Intervet Innovation GmbH, Zur Propstei, 55270 Schwabenheim, Germany.
Vet Microbiol. 2008 Oct 15;131(3-4):277-92. doi: 10.1016/j.vetmic.2008.03.007. Epub 2008 Mar 29.
The transcriptional responses of Pasteurella multocida to eight antibiotics with known mode of actions (MoAs) and one novel antibiotic compound with an unknown MoA were collected to create a compendium of transcriptional profiles for MoA studies. At minimal inhibitory concentration the three bactericidal compounds enrofloxacin, cefquinome and the novel compound had a minor impact on gene regulation with approximately 1% of the P. multocida genome affected, whilst the bacteriostatic compounds florfenicol, tilmicosin, rifampin, trimethoprim and brodimoprim regulated 20% of the genome. Novobiocin was special in that it regulated 40% of all P. multocida genes. Regulation of target genes was observed for novobiocin, rifampin, florfenicol and tilmicosin and signature genes were identified for most antibiotics. The transcriptional profile induced by the novel compound was unrelated to the compendium profiles suggesting a new MoA. The transcription of many P. multocida virulence factors, particularly genes involved in capsule synthesis and export, LPS synthesis, competence, adherence and iron transport were altered in the presence of antibiotics. Virulence gene transcription was mainly negatively affected, however the opposite effect was also observed in the case of rifampin where the up-regulation of the tad locus involved in tight adherence was seen. Novobiocin and trimethoprim caused a marked reduction in the transcription of capsule genes, which correlated with a concomitant reduction of the capsular layer on the surface of P. multocida. The broad negative impact on virulence gene transcription supports the notion that the therapeutic effect of some antibiotics could be a combination of growth and virulence inhibition.
收集了多杀性巴氏杆菌对八种已知作用模式(MoA)的抗生素以及一种作用模式未知的新型抗生素化合物的转录反应,以创建用于作用模式研究的转录谱汇编。在最低抑菌浓度下,三种杀菌化合物恩诺沙星、头孢喹肟和新型化合物对基因调控的影响较小,约1%的多杀性巴氏杆菌基因组受到影响,而抑菌化合物氟苯尼考、替米考星、利福平、甲氧苄啶和溴莫普明调控了20%的基因组。新生霉素很特别,它调控了所有多杀性巴氏杆菌基因的40%。观察到新生霉素、利福平、氟苯尼考和替米考星对靶基因的调控,并为大多数抗生素鉴定了特征基因。新型化合物诱导的转录谱与汇编谱无关,表明其作用模式不同。在抗生素存在的情况下,许多多杀性巴氏杆菌毒力因子的转录发生了改变,特别是参与荚膜合成和输出、脂多糖合成、感受态、黏附和铁转运的基因。毒力基因转录主要受到负面影响,然而在利福平的情况下也观察到了相反的效果,即参与紧密黏附的tad位点上调。新生霉素和甲氧苄啶导致荚膜基因转录显著减少,这与多杀性巴氏杆菌表面荚膜层的相应减少相关。对毒力基因转录的广泛负面影响支持了这样一种观点,即某些抗生素的治疗效果可能是生长抑制和毒力抑制的组合。